Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Conference Call Summary, page-458

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 458 Last

Share
Profile

Follow
DoctorBrad

3,488 Posts.

889

15/08/17

06:04

Post #: 26494263
Share

Originally posted by Levelgrinder ↑

Apologies for the quick replay but trying to address your points, been in DXD from around, or maybe before, your first HC comments. Was the tech that attracted me, the kidney, or (maybe) potential of the diabetebes potential, is a bonus to me. I didn't research your comments elsewhere, you post on some of the same stocks I follow, so sorry to say, and not to offend your ego, I didn't check your profile.

RAP is one to watch no doubt, but dont confuse a study with a FDA-trial, as many have here. But you're a Doctor so I don't need to tell yoj that. Good luck with our investments.

Expand

Who's ego is being offended?

And as for 'confusing' a study (which the Aus trial was) with a study (which the FDA trial was) I'm not really sure what you're saying. They were completely different beasts. The FDA 'study' is the gold standard. It failed to validate the in-house study, thus your sp is languishing in the toilet.

Last edited by DoctorBrad: 15/08/17

RAP Price at posting: 8.1¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 119 more messages in this thread...

First 458 Last

Add RAP (ASX) to my watchlist